Incorporation of bioactive glass in calcium phosphate cement: Material characterization and in vitro degradation

Journal of Biomedical Materials Research - Part A

Volumn 101 A, Issue 8, 2013, Pages 2365-2373

  Renno, A C M ^a,b   Nejadnik, M R ^a   Van De Watering, F C J ^a   Crovace, M C ^c   Zanotto, E D ^c   Hoefnagels, J P M ^d   Wolke, J G C ^a   Jansen, J A ^a   Van Den Beucken, J J J P ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c FEDERAL UNIVERSITY OF SÃO CARLOS   (Brazil)

^d EINDHOVEN UNIVERSITY OF TECHNOLOGY   (Netherlands)

Author keywords

bioactive glass; calcium phosphate cement; degradation; in vitro; poly (D,L lactic co glycolic) acid

Indexed keywords

BIOLOGICAL PERFORMANCE; CALCIUM PHOSPHATE CEMENT; HANDLING PROPERTIES; IN-VITRO; MATERIAL CHARACTERIZATIONS; MORPHOLOGICAL CHARACTERISTIC; OSTEOCONDUCTIVE PROPERTIES; SETTING PROPERTIES;

BIOACTIVE GLASS; BIODEGRADATION; BONE; CEMENTS; COPOLYMERS; DEGRADATION; MICROSPHERES;

SCAFFOLDS;

CALCIUM PHOSPHATE; CEMENT; GLASS; MICROSPHERE; POLYGLACTIN;

ARTICLE; DEGRADATION; IMMERSION; IN VITRO STUDY; PH MEASUREMENT; POROSITY; ROENTGEN SPECTROSCOPY; SCANNING ELECTRON MICROSCOPY; SOLVENT EXTRACTION; X RAY DIFFRACTION;

BONE CEMENTS; BONE SUBSTITUTES; BUFFERS; CALCIUM PHOSPHATES; CERAMICS; LACTIC ACID; POLYGLYCOLIC ACID;

EID: 84879506984     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.34531     Document Type: Article

References (39)

1. Drosse I, Volkmer E, Seitz S, Seitz H, Penzkofer R, Zahn K, Matis U, Mutschler W, Augat P, Schieker M,. Validation of a femoral critical size defect model for orthotopic evaluation of bone healing: A biomechanical, veterinary and trauma surgical perspective. Tissue Eng Part C Methods 2008; 14: 79-88.
2. Välimäki V, Yrjans JJ, Vuorio E, Aro HT,. Combined effect of bone morphogenetic protein-2 gene therapy and bioactive glass microspheres in enhancement of new bone formation. J Biomed Mater Res 2005; 75: 501-509.
3. Hench LL, Xynos ID, Polak JM,. Bioactive glasses for in situ tissue regeneration. J Biomater Sci Polym Ed 2004; 15: 543-562.
4. Dias AG, Lopes MA, Santos JD, Afonso A, Tsuru K, Osaka A, Hayakawa S, Takashima S, Kurabayashi Y,. In vivo performance of biodegradable calcium phosphate glass ceramics using the rabbit model: histological and SEM observation. J Biomater Appl 2006; 20: 253-266.
5. Le Nihouannen D, Saffarzadeh A, Aguado E, Goyenvalle E, Gauthier O, Moreau F, Pilet P, Spaethe R, Daculsi G, Layrolle P,. Osteogenic properties of calcium phosphate ceramics and fibrin glue based composites. J Mater Sci Mater Med 2007; 18: 225-235.
6. Neira IS, Kolen'ko YV, Kommareddy KP, Manjubala I, Yoshimura M, Guitián F,. Reinforcing of a calcium phosphate cement with hydroxyapatite crystals of various morphologies. ACS Appl Mater Interfaces 2010; 2: 3276-3284.
7. van de Watering FCJ, van den Beucken JJ, Walboomers XF, Jansen JA,. Calcium phosphate/poly(D,L-lactic-co-glycolic acid) composite bone substitute materials: Evaluation of temporal degradation and bone ingrowth in a rat critical-sized cranial defect. Clin Oral Implants Res 2012; 23: 151-159.
8. Link DP, van den Dolder J, van den Beucken JJ, Cuijpers VM, Wolke JG, Mikos AG, Jansen J,. Evaluation of the biocompatibility of calcium phosphate cement/PLGA microparticle composites. J Biomed Mater Res A 2008; 87: 760-769.
9. Li M, Liu X, Liu X, Ge B,. Calcium phosphate cement with BMP-2-loaded gelatin microspheres enhances bone healing in osteoporosis: A pilot study. Clin Orthop Relat Res 2010; 468: 1978-1985.
10. Habraken WJ, Wolke JG, Mikos AG, Jansen JA,. Injectable PLGA microsphere/calcium phosphate cements: Physical properties and degradation characteristics. J Biomater Sci Polym Ed 2006; 17: 1057-1074.
11. Leeuwenburgh SC, Jansen JA, Mikos AG,. Functionalization of oligo(poly(ethylene glycol)fumarate) hydrogels with finely dispersed calcium phosphate nanocrystals for bone-substituting purposes. J Biomater Sci Polym Ed 2007; 18: 1547-1564.
12. Félix Lanao RP, Leeuwenburgh SCG, Wolke JGC, Jansen JA,. In vitro degradation rate of apatitic calcium phosphate cement with incorporated PLGA microspheres. Acta Biomater 2011; 7: 3459-3468.
13. Hutmacher DW, Schantz JT, Lam CX, Tan KC, Lim TC,. State of the art and future directions of scaffold-based bone engineering from a biomaterials perspective. J Tissue Eng Regen Med 2007; 1: 245-260. Review.
14. Wang U, Shenwu X, Li C, Feng MF,. Synthesis, characterization, biodegradation, and drug delivery application of biodegradable lactic /glycolic acid polymers. I. Synthesis and characterization. J Biomater Sci. Polymer Ed 2000; 11: 301-318.
15. Habraken WJ, Wolke JG, Mikos AG, Jansen JA,. PLGA microsphere/calcium phosphate cement composites for tissue engineering: in vitro release and degradation characteristics. J Biomater Sci Polym 2008; 19: 1171-1188.
16. Félix Lanao RP, Leeuwenburgh SCG, Wolke JGC, Jansen JA,. Bone response to fast-degrading, injectable calcium phosphate cements containing PLGA microparticles. Biomaterials 2011; 32: 8839-8847.
17. Wu XS, Wang N,. Synthesis, characterization, biodegradation, and drug delivery application of biodegradable lactic/glycolic acid polymers. II. biodegradation. J Biomater Sci Polym Ed 2001; 12: 21-34.
18. Kim J, McBride S, Tellis B, Alvarez-Urena P, Song YH, Dean DD, Sylvia VL, Elgendy H, Ong J, Hollinger JO,. Rapid-prototyped PLGA/β-TCP/ hydroxyapatite nanocomposite scaffolds in a rabbit femoral defect model. Biofabrication 2012; 4: 025003.
19. Vert M, Mauduit J, Li S,. Biodegradable materials that are gradually replaced by hard tissue are required for bone tissue engineering, allowing complete bone regeneration. Biomaterials 1994; 15: 1209-1213.
20. Ruhe P, Hedberg E, Padron NT, Spauwen P, Jansen J, Mikos A,. RhBmp-2 release from injectable poly(dl-lactic-co-glycolic acid)/calciumphosphate cement composites. J Bone Joint Surg 2003; 85: 75-81.
21. Bodde EW, Habraken WJ, Mikos AG, Spauwen PH, Jansen JA,. Effect of polymer molecular weight on the bone biological activity of biodegradable polymer/calciumphosphate cement composites. Tissue Eng Part A 2009; 15: 3183-3191.
22. Liao H, Walboomers XF, Habraken WJ, Zhang Z, Li Y, Grijpma DW, Mikos AG, Wolke JG, Jansen JA,. Injectable calcium phosphate cement with PLGA, gelatin and PTMC microspheres in a rabbit femoral defect. Acta Biomater 2011; 7: 1752-1759.
23. Bodde EW, Boerman OC, Russel FG, Mikos AG, Spauwen PH, Jansen JA,. The kinetic and biological activity of different loaded rhBMP-2 calcium phosphate cement implants in rats. J Biomed Mater Res A 2008; 87: 780-791.
24. Lu HH, Tang A, Oh SC, Spalazzi JP, Dionisio K,. Compositional effects on the formation of a calcium phosphate layer and the response of osteoblast-like cells on polymer-bioactive glass composites. Biomaterials 2005; 26: 6323-6334.
25. Maquet V, Boccaccini AR, Pravata L, Notingher I, Jérôme R,. Preparation, characterization, and in vitro degradation of bioresorbable and bioactive composites based on bioglass-filled polylactide foams. J Biomed Mater Res A 2003; 66: 335-346.
26. Vogel M, Voigt C, Knabe C, Radlanski RJ, Gross UM, Müller-Mai CM,. Development of multinuclear giant cells during the degradation of Bioglass® particles in rabbits. J Biomed Mater Res A 2004; 70: 370-379.
27. Xynos ID, Edgar AJ, Buttery LD, Hench LL, Polak JM,. Ionic products of bioactive glass dissolution increase proliferation of human osteoblasts and induce insulin-like growth factor II mRNA expression and protein synthesis. Biochem Biophys Res Commun 2000; 24: 461-465.
28. Schepers EJ, Ducheyne P,. Bioactive glass particles of narrow size range for the treatment of oral bone defects: A 1-24 month experiment with several materials and particle sizes and size ranges. J Oral Rehabil 1997; 24: 171-181.
29. Peitl O, Zanotto ED, Serbena FC, Hench LL,. Compositional and microstructural design of highly bioactive P2O5-Na2O-CaO-SiO2 glass-ceramics. Acta Biomater 2012; 8: 321-332.
30. Moura J, Teixeira LN, Ravagnani C, Peitl O, Zanotto ED, Beloti MM, et al,. In vitro osteogenesis on a highly bioactive glassceramic (Biosilicate®). J Biomed Mater Res A 2007; 82: 545-557.
31. Zanotto ED, Ravagnani C, Peitl O, Panzeri H, EHL. Process and compositions for preparing particulate, bioactive or resorbable biosilicates for use in the treatment of oral ailments, WO 2004/074199, Fundação Universidade Federal De São Carlos; 20 Feb. 2004, Int. C. C03C10/00.
32. Day RM, Maquet V, Boccaccini AR, Jérôme R, Forbes A,. In vitro and in vivo analysis of macroporous biodegradable poly(D,L-lactide-co- glycolide) scaffolds containing bioactive glass. J Biomed Mater Res A 2005; 75: 778-787.
33. Qi X, Ye J, Wang Y,. Improved injectability and in vitro degradation of a calcium phosphate cement containing poly(lactide-co-glycolide) microspheres. Acta Biomater 2008; 4: 1837-1845.
34. Bigi A, Bracci B, Cojazzi G, Panzavolta S, Roveri N,. Drawn gelatin films with improved mechanical properties. Biomaterials 1998; 19: 2335-2340.
35. Driessens FCM, Flanell JA, Boltong MG, Khairoun I, Ginebra MP,. Osteotransductive bone cements. Proc Inst Mech Eng H 1998; 212: 427-435.
36. Zhang R, Ma PX,. Poly(alpha-hydroxyl acids)/hydroxyapatite porous composites for bone-tissue engineering. I. Preparation and morphology. J Biomed Mater Res 1999; 44: 446-455.
37. Kaufmann EA, Ducheyne P, Shapiro IM,. Effect of varying physical properties of porous, surface modified bioactive glass 45S5 on osteoblast proliferation and maturation. J Biomed Mater Res 2000; 52: 783-796.
38. Verrier S, Blaker JJ, Maquet V, Hench LL, Boccaccini AR,. PDLLA/Bioglass composites for soft-tissue and hard-tissue engineering: An in vitro cell biology assessment. Biomaterials 2004; 25: 3013-3021.
39. Yang Y, Magnay JL, Cooling L, El HA,. Development of a 'mechano-active' scaffold for tissue engineering. Biomaterials 2002; 23: 2119-2126. Nível Superior